-transparent.png){kind=logo}
Bromocriptine lowers plasma ACTH levels in patients with pituitary-dependent Cushing's syndrome. It seemed possible that the drug would also be effective in patients who had been adrenalectomised for the disease. The effect of 5.0 mg of bromocriptine on plasma ACTH and prolactin levels in 13 patients, bilaterally adrenalectomised for pituitary-dependent Cushing's syndrome, was therefore studied. In only one patient was a fall in plasma ACTH observed. This may be of doubtful significance since marked spontaneous fluctuation in plasma ACTH levels were found in the five patients tested. Bromocriptine lowered the plasma prolactin in all of the patients, including two with hyperprolactinaemia.
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
February 1990,
Clinical endocrinology,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
October 2015,
European journal of endocrinology,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
October 1983,
Clinical endocrinology,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
August 1976,
The Journal of endocrinology,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
April 1978,
Casopis lekaru ceskych,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
November 1992,
The Journal of clinical endocrinology and metabolism,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
March 1960,
Annals of internal medicine,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
January 2008,
JSLS : Journal of the Society of Laparoendoscopic Surgeons,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
January 1997,
The Journal of urology,
N O'Mullane, and
B Walker, and
J Jefferson, and
L Hipkin, and
M Diver, and
C Davis
September 1981,
Schweizerische medizinische Wochenschrift,
